Shows / Diagnosing Dx
Diagnosing Dx
How do we transform cutting-edge scientific discoveries into life-saving diagnostics? On Diagnosing Dx, we explore the scientific innovation driving diagnostics forward, unpack industry challenges, and spotlight success stories. Join us as we speak with leading researchers and innovators at the forefront of Dx. Learn to: 🔹 Navigate industry challenges 🔹 Understand emerging science 🔹 Strategise for growth 🔹 Gain future-focused insight Essential listening for everyone involved in bringing new…
Episodes
Diagnosing DxIs AI About to Redefine What a Diagnostics Company Does? Sivan Bercovici, CTO & CBO - Karius
In this episode of Diagnosing Dx, David Filby is joined by Sivan Bercovici, Chief Technology Officer and Chief Business Officer at Karius. With more than two…
Diagnosing DxCan AI Help Us Treat Cancer Without Overtreating Patients? Oliver Bathe, Qualisure Diagnostics
In this episode of Diagnosing Dx, David Filby is joined by Dr Oliver Bathe, Founder and CEO of Qualisure Diagnostics. After more than 25 years as a surgical…
Diagnosing DxCould Genomic Testing Be as Accessible as a Smartphone? Ana Cornell, CEO & Founder of Acorn Genetics
In this episode of Diagnosing Dx, David Filby is joined by Ana Cornell, Founder and CEO of Acorn Genetics. Ana started Acorn after experiencing first-hand how…
Diagnosing DxCould High Frequency Monitoring Transform Autoimmune Care? Kavya Swaminathan
In this episode of Diagnosing Dx, David Filby is joined by Kavya Swaminathan, PhD, Co-Founder and CEO of Kascaid. An immunologist and proteomics scientist by…
Diagnosing DxCould a 10-Minute Test Stop Unnecessary Antibiotic Prescribing? Paul Kase, CCO - Lumos Diagnostics
In this episode of Diagnosing Dx, David Filby is joined by Paul Kase, Chief Commercial Officer at Lumos Diagnostics. Paul brings 30 years of healthcare…
Diagnosing DxWill Payer-Dependent Diagnostics Companies Get Left Behind? Marty Keiser, Founder at IVBH / Mammogen
In this episode of Diagnosing Dx, David Filby is joined by Marty Keiser, Founder and CEO of IVBH. After beginning his career in asset management and capital…
Diagnosing DxWhat If the Patients Who Need Your Test Are Already Hiding in the EHR? Sagacity Diagnostics
In this episode of Diagnosing Dx, David Filby is joined by Raymond Tarr, Founder of Sagacity Diagnostics. Raymond brings more than 25 years of experience…
Diagnosing DxCan Strategic Partnerships Save Diagnostics Innovation? Robert Carlson
In this episode of Diagnosing Dx, David Filby is joined by Robert Carlson, Founder and President of Life Science Dx Consulting. Robert brings 30 years of…
Diagnosing DxCould More Frequent Blood Testing Transform How We Detect Disease?
In this episode of Diagnosing Dx, David Filby is joined by Octavian Florescu, CEO of In Diagnostics. An electrical engineer and microchip designer by training…
Diagnosing DxWhy Are Vector-Borne Infections Still So Difficult to Diagnose?
In this episode of Diagnosing Dx, David Filby is joined by Nicole Bell, CEO of Galaxy Diagnostics. Nicole’s route into vector-borne disease diagnostics is…
Diagnosing DxWhat Can Diagnostics Founders Learn From Two Successful Exits? Andrew Miller
In this episode of Diagnosing Dx, David Filby is joined by Andrew Miller, a diagnostics founder, advisor and two-time exited CEO. A scientist by training…
Diagnosing Dx98% of Cancer Patients Outside the US Miss Genomic Testing. Can AI Change That?
In this episode of Diagnosing Dx, David Filby is joined by Travis Wold, Chief Executive Officer at Imagenomix. Travis brings experience across cancer…
Diagnosing DxCould 20-Minute Hormone Testing Transform Patient Care? Nedal Safwat, SVP at Canatu
In this episode of Diagnosing Dx, David Filby is joined by Nedal Safwat, Senior Vice President of Medical Diagnostics at Canatu and President of Canatu Inc…
Diagnosing DxCould a $127M Seed Round Change Women's Health Forever? - Dean Remy, Co-Founder @ Mativa Dx
In this episode of Diagnosing Dx, David Filby is joined by Dean Remy, Co-Founder and Chief Commercial Officer at Mativa Diagnostics. Dean brings 35 years of…
Diagnosing DxRed Drop’s Bet on Pain-Free Blood Collection and the Next Wave of Diagnostics
In this episode of Diagnosing Dx, David Filby is joined by Thomas Briggs, Chief Growth Officer at RedDrop Dx. Thomas brings more than 25 years of diagnostics…
Diagnosing DxWhy Cancer Patients Still Die From Infections We Can't Diagnose - Karius
In this episode of Diagnosing Dx, David Filby is joined by Alec Ford, Chief Executive Officer at Karius. Alec brings decades of leadership experience across…
Diagnosing DxCan AI Rescue Cancer Drugs That Clinical Trials Say Have Failed?
In this episode of Diagnosing Dx, David Filby is joined by Alexander Bagaev, Chief Product Officer at BostonGene. Alexander has spent more than a decade…
Diagnosing DxWhat If We Could Test Depression Drugs Before Patients Take Them? Dr Talia Cohen Solal - NeuroKaire
In this episode of Diagnosing Dx, David Filby is joined by Talia Cohen Solal, CEO at NeuroKaire. Talia is a neuroscientist by training who spent more than a…
Diagnosing DxWhy AI Multiomics Will Replace Ultrasound in Liver Cancer Screening with Bharat Tewarie
In this episode of Diagnosing Dx, David Filby is joined by Bharat Tewarie, MD, MBA, CEO at Helio Genomics. Bharat has led Helio Genomics since July 2025…
Diagnosing DxStart with Reimbursement and Work Backwards - Jonathan Romanowsky
In this episode of Diagnosing Dx, I’m joined by Jonathan Romanowsky, co-founder of Inflammatix and Principal at Kadima Spark.Jonathan shares lessons from…
Diagnosing DxThe EU Market Access Playbook for Diagnostics Companies - Svetlana Nikic
In this episode of Diagnosing Dx, I’m joined by Svetlana Nikic, Founder of Precision Oncology Consulting.Svetlana shares her journey from Roche and Illumina…
Diagnosing DxThe Future of Kidney Transplant Monitoring: Moving Beyond Biopsies - Sara Barrington, CEO of Verici Dx
In this episode of Diagnosing Dx, I’m joined by Sara Barrington, CEO at Verici Dx. Sara explains how Verici Dx is tackling one of the biggest unresolved…
Diagnosing DxHow Cleveland Diagnostics Is Redefining Prostate Cancer Testing
In this episode of Diagnosing Dx, I’m joined by Arnon Chait, PhD, MBA, Chief Innovation Officer at Cleveland Diagnostics.Arnon shares his journey from NASA…
Diagnosing DxFrom Single Cell to Atera: The Future of Biology Measured at Scale - Serge Saxonov, Co-founder & CEO of 10x Genomics
In this episode of Diagnosing Dx, I’m joined by Serge Saxonov, Co-founder and CEO of 10x Genomics, a leader in single cell and spatial biology. Serge shares…
Diagnosing DxTrue At-Home Diagnostics: Reshaping Infectious Disease with Nathalya Mamane, CEO of Anywhere Dx
In this episode of Diagnosing Dx, I’m joined by Nathalya Mamane, Co-Founder and CEO at Anywhere Dx. Nathalya shares the origin story behind Anywhere Dx and how…
Diagnosing DxThe New Rules of Diagnostics: Lean Teams, Faster Revenue, Smarter Growth - MJ Hymes, i5 BioPartners
In this episode of Diagnosing Dx, I’m joined by MJ Hymes, Managing Partner at i5 BioPartners. MJ shares his journey from molecular biology into the commercial…
Diagnosing Dx“Wait and Watch” Is Failing Cancer Patients — Harbinger Health on What Comes Next
In this episode of Diagnosing Dx, I’m joined by Ajit Singh, CEO at Harbinger Health.Ajit has spent decades building, scaling, and investing in diagnostics…
Diagnosing DxWomen Wait 11 Years for a Diagnosis, Endometrics Are Changing That - Yana Aznavour
This week I’m joined by Yana Aznavour, MD, PhD, OB-GYN surgeon and Founder & CEO of Endometrics. We unpack one of the biggest failures in modern healthcare…
Diagnosing DxFinding Lung Cancer Before It’s Too Late: From Uncertainty to Action
In this episode of Diagnosing Dx, I’m joined by Maria Zannes, Chief Executive Officer and Director at bioAffinity Technologies. Maria shares her journey from…
Diagnosing DxScaling Precision Medicine: Faster Reports, Smarter Trials, Better Care - Garreth Hippe at GenomOncology
In this episode of Diagnosing Dx, I’m joined by Garreth Hippe, Chief Commercial Officer at GenomOncology, a software company helping turn complex genomic…
Diagnosing DxThe Women’s Health Data Gap: Why Diagnostics Are Decades Behind - Marra Francis, MD
In this first episode of Diagnosing WDx, the new women’s health-focused sister series from Diagnosing Dx, I’m joined by Marra Francis, MD, board-certified…
Diagnosing DxThe $4 Billion Problem in Lyme Diagnostics with Aces Diagnostics
In this episode of Diagnosing Dx, I’m joined by Tammy Crawford, Chief Executive Officer, and Holly Ahern, Chief Scientific Officer at Aces Diagnostics, a…
Diagnosing DxReimbursement-First Thinking in Early-Stage Diagnostics with OraLiva
In this episode of Diagnosing Dx, I’m joined by Spencer Price, Chief Executive Officer at OraLiva, a company building an AI-powered precision diagnostic…
Diagnosing DxBuilding Diagnostics Without Building Hardware: Checktor’s Strategic Play
In this episode of Diagnosing Dx, I’m joined by Jake Lesinski, Co-founder and CEO of Checktor Biosciences, an ETH Zurich spin-out building a CRISPR-based…
Diagnosing DxWhy Great Diagnostics Fail: Turning Single-Cell Science Into a Real Product
In this episode of Diagnosing Dx, I’m joined by Zivjena Vucetic, Chief Medical Officer at Mission Bio, to explore what it really takes to turn breakthrough…
Diagnosing DxWhy Diagnostic Labs Are Breaking — and How The Proficient Lab Is Fixing It - Unika Alexander
In this episode of Diagnosing Dx, I’m joined by Unika Alexander, Co-Founder and CEO of The Proficient Lab, to unpack what’s really happening inside today’s…
Diagnosing DxAGED Dx: Grit, Purpose, and the Fight to Diagnose Liver Disease Early - Rachel Zayas, CEO
In this episode of Diagnosing Dx, I’m joined by Rachel Zayas, CEO of AGED Diagnostics, a company tackling one of the most underdiagnosed and overlooked…
Diagnosing DxHead & Neck Cancer Is Still Found Too Late — And OrisDX Is Changing That
In this episode of Diagnosing Dx, I’m joined by Harald Steltzer, CEO of OrisDX, a company tackling one of the most overlooked gaps in diagnostics: early…
Diagnosing DxEXCLUSIVE: Inside VedaBio - The Breakthrough That Could Redefine Point-of-Care Diagnostics
In this episode of Diagnosing Dx, I sit down with Frédéric D. Sweeney, President & CEO of VedaBio, the company pioneering a completely new class of molecular…
Diagnosing DxThe 20-Year Head Start: How Amprion Is Transforming Neurodiagnostics
In this episode, Dr. Russ Lebovitz, CEO of Amprion, explains why detecting misfolded proteins years before symptoms begin could completely reshape how we…
Diagnosing DxInside the Single-Cell Revolution: One Biosciences’ Path to Clinical Reality
In this episode of DiagnosingDx, I’m joined by Wissam Hamou, Chief Operating Officer of One Biosciences, a company bringing single-cell diagnostics out of the…
Diagnosing DxThe One-Hour Test That Could Stop Sepsis - Mustafa Al-Adhami from Astek Diagnostics
In this episode of Diagnosing Dx, I’m joined by Mustafa Al-Adhami, CEO and founder of Astek Consulting. We dive into how his team is building a rapid testing…
Diagnosing DxThe Rise of AI in Diagnostics & Clinical Trials - Slava Akmaev, Chief AI Officer
In this episode of Diagnosing Dx, I’m joined by Slava Akmaev, Chief AI Officer and COO at BPGbio, and one of the earliest pioneers applying AI to diagnostics…
Diagnosing DxFrom Type 1 Detection to Total Health: How KiHealth is Redefining Preventive Testing
In this episode of Diagnosing Dx, I sit down with Jenna Anderson, CEO of KiHealth, the company behind a breakthrough diagnostic test that can detect Type 1…
Diagnosing DxThe Shelf Problem: Why Life-Saving Diagnostics Stay Hidden - Sally and BJ
In this episode of Diagnosing Dx, I’m joined by Sally Bowden and BJ Kerns, founders of P3 Consulting, who help early-stage diagnostics startups navigate the…
Diagnosing DxTasso’s Painless Future of Blood Testing: From Fear to Freedom
In this episode of Diagnosing Dx, I’m joined by Ben Casavant, Co-founder and CEO of Tasso, a company redefining how blood testing works. Ben shares how a PhD…
Diagnosing DxBuilding Better Labs: Julie Ballard on CLIA, LDTs, and the Hidden Costs of Getting It Wrong
In this episode of Diagnosing Dx, I’m joined by Julie Ballard, founder of Carrot Clinical and Tiger Team Bio, who has helped shape leading diagnostics…
Diagnosing DxJuniper Genomics: Rewriting the IVF Playbook for Hope, Science, and Access - Kaylene Ready
This week on Diagnosing Dx, I’m joined by Kaylene Ready, Chief Product Officer at Juniper Genomics, a company transforming the future of IVF through whole…
Diagnosing DxWorkflow, Customers, and Course Corrections: Scott O’Brien on Scaling GenMark
This week on Diagnosing Dx, I’m joined by Scott O’Brien, who helped lead GenMark from a small startup to a $1.8 billion acquisition by Roche. Scott shares how…
Diagnosing DxBench in a Box: Redefining PCR for Anywhere, Anytime Diagnostics - Josh Smith
This week on Diagnosing Dx, I’m joined by Josh Smith, founder of Bench in a Box and scientist with a background in genetics and microbiology. Josh shares the…
Diagnosing DxGoing Global: Victoria Polyanskaya on Expanding Diagnostics Beyond the US
This week on Diagnosing Dx, I’m joined by Victoria Polyanskaya, a healthcare leader with over 10 years of experience who is driving global expansion for…
Diagnosing DxMission Meets Money: Dean Remy on Fundraising and the Future of Diagnostics
This week on Diagnosing Dx, I’m joined by Dean Remy, a 35-year veteran of the life sciences industry, founder, and fundraising strategist. Dean shares his…
Diagnosing DxInside BioFire: Culture, Growth, and the Rocket Ship Ride - Rachel Jones
This week on Diagnosing Dx, I’m joined by Rachel Jones,former Chief Commercial Officer at BioFire and now at VedaBio. Rachel shares her remarkable journey from…
Diagnosing DxFrom Hypothesis-Driven to Hypothesis-Free: The Future of Dx with Brad Murray
This week on Diagnosing Dx, I’m joined by Bradley Murray, CEO and co-founder of Delve Bio. Bradley shares his journey from academic research, success as a…
Diagnosing DxTruth-Seeking in Diagnostics: Lessons from Genomic Health to Mental Health - Tara Maddala
This week on Diagnosing Dx, I’m joined by Tara Maddala,statistician, diagnostics veteran, and founder of Pandora Bio and Tiger Team Bio, whose career also…
Diagnosing DxFrom Science to Sales — The Hard Truths of Commercializing Diagnostics Today - Mark Oldroyd
This week on Diagnosing Dx, I’m joined by Mark Oldroyd, a commercialisation strategist with over 30 years in healthcare, including leadership roles at…
Diagnosing DxAI, Virtual Staining & the Future of Pathology – James Kelley
This week on Diagnosing Dx, I’m joined by James Kelley, Chief Medical Officer at Pictor Labs and a respected leader in lab medicine and diagnostics. We explore…
Diagnosing DxBuilding Assays, Battling COVID on the Frontline, and What’s Next in Dx – Vincent Funari
This week on Diagnosing Dx, I’m joined by Vincent Funari, a genomics leader whose career spans from the Human Genome Project to pioneering liquid biopsy assays…
Diagnosing DxLDT's safe for now, but for how long? What startups must know – Mort Minaee
On this week’s episode of Diagnosing Dx, I’m joined by Mort Minaee, a seasoned regulatory strategist with over 35 years of experience at companies like Roche…
Diagnosing DxHow Pictor Is Scaling Proteomics for Faster, Smarter Testing – Janine McMurdie
This week on Diagnosing Dx, I’m joined by Janine McMurdie, Chief Commercial Officer at Pictor, a company unlocking the next wave of innovation in diagnostics…